Флуклоксациллин

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Флуклоксациллин

Флуклоксациллин (Flucloxacillin) is a medicinal entity used to combat bacterial infections and is classified as an antibiotic. It functions by directly killing susceptible bacteria and belongs to the beta-lactam antibacterial family, a broad group defined by a common chemical structure.


Quick Facts about Флуклоксациллин

Property Description
Active ingredient Flucloxacillin (typically as Flucloxacillin sodium)
Form Capsules, Oral Solution, Powder for Injection/Infusion
Pharmacological class Penicillinase-resistant penicillin, beta-Lactam antibacterial
Common use Fighting bacterial infections
Origin Semi-synthetic (derived from natural penicillin)

What Type of Medicine is Флуклоксациллин?

Флуклоксациллин is an antibiotic belonging to the penicillin class, specifically categorized as a penicillinase-resistant penicillin. This drug is semi-synthetic, meaning its core structure originates from natural penicillin but has been chemically modified to improve its characteristics and stability. The characteristic of being a penicillinase-resistant agent is clinically recognized for its efficacy against staphylococci resistant to standard penicillins. Unlike older penicillin drugs, this chemical modification ensures that Флуклоксациллин is stable against bacterial enzymes known as penicillinases or beta-lactamases, which many harmful bacteria use to neutralize standard penicillin agents. Its unique resistance makes it a specific, narrow-spectrum agent used primarily against certain beta-lactamase-producing Gram-positive organisms, such as Methicillin-susceptible Staphylococcus aureus (MSSA).


Composition, Forms, and General Purpose

The active ingredient in this medicine is solely Flucloxacillin, typically supplied as the Flucloxacillin sodium salt. This INN (International Nonproprietary Name) formulation is available globally under various trade names, such as Floxacillin or Staphlipen. This single-entity product is available in several distinct dosage forms, including oral capsules and an oral solution for patients who may have difficulty swallowing, as well as a powder for solution for injection or infusion for parenteral administration. The general purpose of Флуклоксациллин is to achieve a bactericidal effect by interfering with the synthesis of the bacterial cell wall, causing the bacteria to rupture and die. The active substance, Flucloxacillin, maintains a robust action against susceptible bacteria, which is the key to its clinical efficacy. This mechanism provides a decisive way to resolve infections caused by specific, susceptible bacterial strains.

What side effects are possible with Флуклоксациллин?

Possible side effects and safety information

The safety profile for Flucloxacillin is formally classified by regulatory authorities based on the System Organ Classes (SOC) affected and the expected frequency of the reactions. Most commonly documented adverse reactions affect the Gastrointestinal Disorders system, classified as Common, which may include nausea and diarrhea. Uncommon effects primarily involve the Skin and Subcutaneous Tissue Disorders, such as mild rash and urticaria.

Classification Example Reactions (SOC)
Common Nausea, Diarrhea (Gastrointestinal Disorders)
Uncommon Rash, Urticaria (Skin Disorders)
Rare Hepatitis, Cholestatic Jaundice (Hepatobiliary Disorders); Anaphylaxis (Immune System Disorders)
Very Rare SJS, TEN, Interstitial Nephritis, Blood Disorders

The regulatory profile highlights serious, though Rare, risks, including Anaphylactic Shock and severe Hepatobiliary Disorders such as hepatitis and cholestatic jaundice. The onset of these severe hepatic reactions may be delayed for up to two months after treatment cessation, a time-related safety pattern explicitly noted in official labeling. Very Rare serious adverse events include Severe Cutaneous Adverse Reactions (SCARs) like Stevens-Johnson Syndrome (SJS).

Safety Restrictions and Populations: Flucloxacillin is contraindicated in individuals with a known history of hypersensitivity to penicillin antibiotics or a previous history of Flucloxacillin-associated jaundice. Specific safety considerations are documented for older adults and those with pre-existing hepatic dysfunction, who have an officially documented increased risk of severe adverse effects.

Overdose and Emergency Response

Overdose and when to seek help

The official descriptions of Flucloxacillin overdose focus on two main categories of risk: common gastrointestinal presentations and severe systemic or neurological effects. Overdose may initially manifest with nausea, vomiting, and diarrhoea. More serious presentations, including neurological disorders and convulsions, are documented risks associated with high intravenous doses, particularly in patients with pre-existing renal impairment.

Systemic risks include electrolyte disturbances such as Hypokalaemia (low potassium levels) and High Anion Gap Metabolic Acidosis (HAGMA), the latter being a serious condition requiring urgent medical intervention. Special population considerations exist, including the risk of kernicterus in jaundiced newborns following high parenteral doses.

Regulatory guidance is explicit: immediate medical attention must be sought if an overdose is suspected. This action is required even if no signs of discomfort or poisoning are immediately apparent. Patients must contact emergency services or go to the nearest hospital emergency department. The management documented in official labeling is symptomatic and supportive, as no specific antidote is known; this may include monitoring of potassium levels and renal status.

Therapeutic Uses of Флуклоксациллин

What Флуклоксациллин treats: Main Uses and Benefits

Флуклоксациллин is commonly used in situations involving certain distressing symptoms linked to infection. It is applied across domains where additional symptomatic support is needed and contributes to easing the overall symptom load.

This medication is applied across domains where additional symptomatic support is needed for conditions presenting with acute episodes. This commonly includes symptoms related to skin and soft tissue discomfort (like cellulitis, boils, and infected wounds), as well as certain symptom patterns seen in bone, joint, and respiratory tract issues.

It is relevant for easing localized symptoms like intense pain, increasing redness, and swelling. Supporting this benefit, the medication also assists in managing symptoms related to systemic imbalance, such as fever and general malaise, that may accompany infection.

The supportive therapeutic benefit of this medication may help ease challenging symptoms, assisting with general patient comfort.

Quick Fact: Supports Easing of Localized Discomfort

When applied appropriately, the medication assists with maintaining functional stability and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Флуклоксациллин — Official Regulatory Information

Contraindicated Populations The medicine must not be used in patients with a known hypersensitivity to Flucloxacillin or any other β-lactam antibiotics (penicillins, cephalosporins) [1.2]. Use is also absolutely prohibited for individuals with a previous history of Flucloxacillin-associated jaundice or hepatic dysfunction [1.2].

Eligibility Scope Status / Rule
Populations Allowed Most Adults and Children (various age sub-groups) [1.1, 1.2].
Conditional Use: Organ Function Severe renal failure (creatinine clearance < 10 mL/min) requires dose adjustment consideration [1.2]. Hepatic dysfunction requires use with caution [1.2].
Conditional Use: Age Newborns/Neonates require special caution due to the risk of hyperbilirubinaemia [1.2]. Caution is also advised for patients ge 50 years of age with serious underlying disease [1.2].
Conditional Use: Reproductive Status Use in pregnancy and lactation is permitted only when the potential benefits outweigh the potential risks [1.2].

Official Eligibility Statements Regulatory documents classify use based on historical reactions and current physiology. Eligibility is strictly denied due to contraindications relating to allergy history and previous Flucloxacillin-linked liver damage [1.2]. For groups like neonates, older adults, and those with organ impairment, the official labeling imposes conditional use status, requiring special assessment before administration [1.2]. This framework dictates who is officially permitted to use the medicine and under what labeled constraints.

What should I know about interactions with other medicines?

Flucloxacillin can interact with several other medicines, altering their effects or increasing the risk of side effects. It is important to inform your doctor or pharmacist about all prescription, over-the-counter, and herbal products you are taking.

Key Interactions to Monitor

Concomitant Medicine Potential Interaction Effect Management Recommendation
Warfarin (an anticoagulant) Flucloxacillin can reduce the anticoagulant effect of warfarin, leading to a subtherapeutic International Normalized Ratio (INR). This may increase the risk of blood clots. Close monitoring of INR is essential during and immediately following the course of flucloxacillin. Warfarin dosage may require adjustment.
Methotrexate (an anti-inflammatory/chemotherapy agent) There is a risk of increased methotrexate toxicity, particularly in patients with pre-existing kidney problems, poor nutrition, or high-dose methotrexate use. Use with caution; close monitoring for signs of toxicity is required.
Probenecid (used for gout) Probenecid delays the excretion of flucloxacillin, resulting in higher and more prolonged levels of the antibiotic in the bloodstream. This interaction may be exploited therapeutically, but caution is necessary to avoid excessively high antibiotic levels.
Paracetamol/Acetaminophen Co-administration may lead to an increased risk of a blood and fluid abnormality called high anion gap metabolic acidosis, especially in patients with kidney impairment, sepsis, or malnutrition. Use together with caution and under medical supervision, especially in high-risk groups.

It is generally recommended to avoid concurrent use with vaccines containing live bacterial cultures, as flucloxacillin may reduce their effectiveness. Consult with a healthcare professional before combining flucloxacillin with any other product.

Mechanism of Action

How Флуклоксациллин Works: Mechanism of Action

The primary action of Флуклоксациллин is the irreversible inhibition of bacterial Penicillin-Binding Proteins (PBPs), a class of enzymes essential for constructing the cell wall. By covalently binding to these enzyme targets, the drug blocks the final peptidoglycan cross-linking reaction required for structural integrity. This inhibition initiates a cascade leading to acute osmotic instability and failure of the cell wall.

Inhibition of PBPs simultaneously triggers the unregulated activity of the bacteria's internal breakdown enzymes, called autolysins. This dual effect—preventing cell wall synthesis while activating its degradation—results in the rapid and complete rupture (cell lysis) of the bacterial structure, a process that results in the drug’s bactericidal (bacteria-killing) physiological effect.

A defining mechanistic feature is the presence of a bulky isoxazolyl side chain. This structural property provides steric hindrance to the bacterial enzyme beta-lactamase (penicillinase), preventing the enzyme from hydrolyzing and deactivating the drug, thereby allowing the bactericidal mechanism to operate against bacterial strains that utilize this common resistance strategy.

Dosage and Administration Information

How to Use Flucloxacillin (Флуклоксациллин): Administration Guidelines

Flucloxacillin administration is standardized across several dosage forms and routes. The medication is primarily available for oral intake as capsules or solution, and for parenteral use via intravenous (IV) or intramuscular (IM) injection. The choice of route depends on the severity of the clinical scenario and the setting of use.


Dosing and Administration Protocol

Category Instructions
Standard Adult Dosing Typically 250 mg to 500 mg per dose for oral forms, or 250 mg to 1 g for parenteral administration. Regimens for severe systemic cases may require up to 8 g daily in divided doses.
Dosing Frequency The standard schedule is in divided doses, most commonly administered six-hourly (four times a day), to maintain consistent therapeutic levels.
Food Relationship (Oral) Oral forms must be taken on an empty stomach, specifically 1 hour before or 2 hours after food, to achieve optimal drug absorption. Oral doses should be swallowed with a full glass of water.
Renal Adjustment Dosage reduction or interval extension is required for patients with severe renal impairment (creatinine clearance < 10 mL/min), ensuring the maximum dose is appropriately limited.

Procedural Structure

The usage protocol mandates adherence to specific steps. The powder for injection requires reconstitution with an appropriate diluent, such as Water for Injections, prior to IV or IM use. IV doses are administered by slow injection or a short infusion over 30 to 60 minutes. If a dose is missed, the general procedure is to take it as soon as remembered, unless the next dose is due shortly, in which case the missed dose should be skipped. The overall duration of therapy is defined by a treating professional and often ranges from 7 to 14 days for standard use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Флуклоксациллин

Evidence for Use in Skin and Soft Tissue Infections

This section will summarize the available evidence, primarily from randomized controlled trials and meta-analyses, which have examined the use of Flucloxacillin for common skin and soft tissue infections. The summary will detail the types of outcomes measured in these studies, such as the rate of symptom change and the need for subsequent treatment. Research exploring interventions for infections like cellulitis, abscesses, and infected wounds, which included Flucloxacillin, has been conducted through short-term randomized controlled trials (RCTs) and subsequent systematic reviews. Findings describe patterns observed in these studies, indicating that, following procedures like draining an abscess, the use of a systemic antibiotic was associated with differences in the rate of symptom change. Furthermore, the specific antibiotic regimen (such as whether an additional antibiotic is required alongside Flucloxacillin for extensive cellulitis) is an area where scientific literature has shown variation, and clear consensus remains to be established across all available research.

Evidence for Use in Serious Systemic Infections

This part of the overview will describe the research base for Flucloxacillin's use in deep-seated infections, including MSSA bacteraemia and osteomyelitis. The focus will be on the structure of the evidence, which is primarily derived from large-scale observational cohort studies, and the survival outcomes (like mortality) that were measured. Studies report how patient outcomes evolved in the observed populations when data related to Flucloxa-cillin were analyzed alongside a different class of antistaphylococcal antibiotic (Cefazolin). The certainty remains low because comparative evidence is lacking from definitive, large-scale RCTs, meaning the results apply only to the observational populations studied.

Evidence in Special Populations, Including Infants with Cystic Fibrosis

Flucloxacillin was studied for use in a prophylactic context in infants newly diagnosed with Cystic Fibrosis (CF). Studies monitored the time it took for the infants to acquire colonization with Pseudomonas aeruginosa (PsA), which is an important outcome for research in this patient group. The core uncertainty is that the specific balance between the observed patterns of Staphylococcus aureus colonization and the possible risk of an earlier acquisition of PsA is the core research uncertainty that ongoing trials aim to address.

Frequently Asked Questions (FAQ)

Common questions about Флуклоксациллин (FAQ)


Q: What are the most common side effects people report when taking Флуклоксациллин?

According to official product information, the most commonly documented adverse reactions are categorized as Common and usually involve minor gastrointestinal disturbances, such as feeling sick (nausea) and diarrhoea. Reactions involving the skin, like a mild rash (urticaria) and other hypersensitivity reactions, are generally classified as Uncommon.


Q: Can Флуклоксациллин cause allergic reactions?

Yes, Flucloxacillin can potentially cause hypersensitivity reactions. These reactions can range from uncommon skin rashes to very rare, serious reactions like anaphylactic shock. Regulatory documents state that the medicine is strictly contraindicated in individuals who have a known history of hypersensitivity to any penicillin antibiotics.


Q: Is Флуклоксациллин suitable for people with kidney problems?

For most patients with mild or moderate kidney impairment, a dose adjustment is not usually required. However, official information indicates that in cases of severe renal failure, a healthcare professional may need to consider dose adjustment or extension of the dose interval, as indicated by regulatory guidance.


Q: Why is Флуклоксациллин often recommended to be taken on an empty stomach?

Regulatory labeling indicates the medicine should be taken on an empty stomach (typically one hour before or two hours after eating). This is because the presence of food in the stomach can hinder the absorption of the medicine, potentially reducing the amount that enters the bloodstream.


Q: What are the signs of a serious allergic reaction to Флуклоксациллин?

Signs of a severe allergic reaction are listed in the product information. These symptoms may warrant urgent medical review. They can include sudden wheezing, swelling of the lips, tongue, or face (angioedema), or the rapid onset of a severe, itchy rash (hives) or difficulty breathing.


Q: Is Флуклоксациллин used to prevent infection after surgery?

Yes, the official indication for Flucloxacillin includes its use as a prophylactic agent. This means it may be used before certain major surgical procedures, such as cardiothoracic (heart/chest) and orthopaedic (bone) surgery, for infection prevention.


Q: Is it common to feel tired while taking Флуклоксациллин?

Tiredness or fatigue is not listed among the most common adverse effects in regulatory documents. However, certain very rare side effects, such as blood disorders or anaemia, have been reported to potentially cause tiredness. If unexplained fatigue is experienced, consulting a healthcare professional is advisable.


Q: Does alcohol interact with Флуклоксациллин?

Regulatory information does not list a direct chemical interaction between Flucloxacillin and alcohol. However, official regulatory documents advise caution regarding alcohol consumption, as it may potentially worsen existing side effects like gastrointestinal upset or place additional strain on the liver.


Q: Are there certain supplements or vitamins that interact with Флуклоксациллин?

Official information indicates that patients should disclose the use of all supplements, herbal remedies, or vitamins to a healthcare professional. This is because these products are not tested in the same way as prescription medications, and the effects of concurrent use are not always fully known.


Q: Can Флуклоксациллин be used during pregnancy?

Regulatory documents describe its use during pregnancy as conditional, stating it is permitted when a healthcare professional determines that the potential benefits outweigh the potential risks. The drug is not associated with an increased risk of malformation in the developing fetus.


Q: Is Флуклоксациллин considered safe for use while breastfeeding?

Flucloxacillin is often used while breastfeeding, as regulatory information suggests only trace quantities of the drug are typically detected in breast milk. However, the possibility of a hypersensitivity reaction (allergic response) in the infant is a factor that remains under consideration.


Q: Are there age restrictions for who can take Флуклоксациллин?

The medicine is approved for use in both adults and children, with specific dosing provided for different paediatric age groups. However, regulatory documents specify that special caution must be used when considering use in newborns and neonates due to certain safety considerations.


Q: What is the required duration for a typical course of Флуклоксациллин?

The overall duration of therapy is detailed in the prescribing information and is typically determined by the treating professional based on the specific infection. For standard use, the course is often described as ranging from 7 to 14 days.


Q: Can I stop taking Флуклоксациллин once I feel better?

Official guidance emphasizes that the full course of medication is intended to be completed, even if symptoms begin to improve or disappear. Stopping the antibiotic course early may allow the infection to persist or return.


Q: Has Флуклоксациллин been studied for treating infections in children?

Yes, regulatory documents provide specific dosage recommendations for the paediatric population, including infants and older children, which is consistent with its authorized use in this patient group.


Q: Does Флуклоксациллин interact with oral contraceptives (birth control pills)?

Regulatory documents state that Flucloxacillin does not directly reduce the efficacy of most hormonal contraceptives. However, if the medicine causes significant vomiting or severe diarrhoea that lasts for more than 24 hours, the contraceptive effect may be reduced.


Q: Is it normal to get a yeast infection after taking Флуклоксациллин?

Yes, oral or vaginal thrush (yeast infections) is listed among the potential side effects. This is a common occurrence with many antibiotics, as they can sometimes lead to the overgrowth of non-susceptible organisms, such as Candida.


Q: Why does the packaging sometimes say Флуклоксациллин contains sodium?

The active ingredient is typically supplied as the Flucloxacillin Sodium salt. As a result, the product contains a measured amount of sodium, which is noted in the packaging for the attention of patients who may be following a controlled sodium diet.


Q: What is the difference between Флуклоксациллин capsules and liquid suspension?

The medicine is generally available in two forms: capsules and a liquid (oral solution/suspension). The liquid form is typically provided to patients, especially children or those who are unable to swallow tablets or capsules easily.


Q: Does Флуклоксациллин affect how blood thinner medications work?

Yes, regulatory documents note an interaction risk with blood thinner medications (anticoagulants) such as Warfarin. Monitoring of blood clotting levels is noted as necessary, as regulatory documents indicate that the anticoagulant dose may require adjustment.


Q: Does Флуклоксациллин treat viral infections?

No, Flucloxacillin is classified as an antibiotic and is specifically indicated for the treatment of bacterial infections. As with all antibiotics, it is not considered effective against viral infections, such as the common cold or flu.


Q: Is resistance to Флуклоксациллин a common issue?

Flucloxacillin is a specific type of penicillin that is resistant to the beta-lactamase enzyme, making it effective against common resistant bacteria like MSSA. However, strains like Methicillin-Resistant S. aureus (MRSA) are typically resistant to Flucloxacillin, which limits its use in certain cases.


Q: What are the main risks associated with taking Флуклоксациллин?

The most serious, though Rare, risks highlighted in the regulatory profile are severe hypersensitivity reactions (including anaphylaxis) and severe hepatobiliary disorders (liver injury or jaundice). The product information emphasizes the existence of these risks, particularly for individuals over 50 or those with underlying serious conditions.


Q: Can Флуклоксациллин make existing medical conditions worse?

Official product information emphasizes that use is conditional in patients with pre-existing conditions, particularly hepatic dysfunction (liver impairment) and other serious underlying diseases. This is because these populations may have an increased risk of experiencing severe liver-related adverse events.


Q: Are there different strengths or dosages of Флуклоксациллин available?

Yes, the medicine is manufactured in multiple strengths for different routes of administration. This includes common oral strengths such as 250 mg and 500 mg capsules, as well as higher strengths for injection or infusion.


Q: What does it mean if my infection is 'resistant' to Флуклоксациллин?

If an infection is officially designated as 'resistant' to Flucloxacillin, it means that the specific bacteria causing the infection is not susceptible to the antibiotic’s mechanism of action. Consequently, the medicine will be ineffective in eliminating that bacterial strain.


Q: Do studies support the use of Флуклоксациллин for bone infections?

Yes, the regulatory labeling and associated research evidence for Flucloxacillin include its indication for use in treating bone and joint infections, such as osteomyelitis. Specific, high-dose and long-duration regimens may be described for chronic cases.


Q: How is Флуклоксациллин eliminated from the body?

According to official pharmacokinetic information, the drug is eliminated primarily through the kidney (renal excretion). A large percentage of the administered dose is recovered in its unaltered active form in the urine shortly after dosing.


Q: Does Флуклоксациллин interact with common cold or flu remedies?

Regulatory information notes a potential interaction with Paracetamol (a common ingredient in cold remedies), particularly in certain high-risk patients (like those with kidney impairment). This co-administration may carry a risk of a specific blood and fluid abnormality called High Anion Gap Metabolic Acidosis (HAGMA).


Q: Is it safe to drive or operate machinery while taking Флуклоксациллин?

Regulatory documents state that the medicine generally has no, or negligible, influence on the ability to drive and use machines. However, if any adverse reaction occurs that affects concentration or physical function, individuals may wish to exercise caution.


Q: What is the relationship between Флуклоксациллин and Staphylococcus bacteria?

Flucloxacillin is categorized as the antibiotic of choice for managing infections caused by Methicillin-Susceptible Staphylococcus aureus (MSSA). Its unique structure makes it resistant to the penicillinase enzyme produced by these common staph strains, allowing it to remain effective against them.


Q: Why do some people need to take Флуклоксациллин for a very long time?

While the standard course is 7–14 days, official documents describe that longer durations of treatment, sometimes up to six months, are specifically required for treating certain serious, deep-seated infections, such as chronic osteomyelitis (bone infection), to ensure complete clearance.


Q: Is it true that taking Флуклоксациллин can alter the results of certain medical tests?

Yes, official product information indicates that the use of penicillins, including Flucloxacillin, may produce false-positive results with certain laboratory tests. These include the direct antiglobulin (Coombs') test and certain methods used to measure glucose in the urine (copper sulphate method).

How should Флуклоксациллин be stored and disposed of?

How to Store and Dispose of Flucloxacillin

Flucloxacillin storage must adhere strictly to regulatory conditions to maintain stability. Keep the medicine out of the sight and reach of children and store the solid forms (capsules, powder) at a temperature not exceeding 25 C or 30 C, depending on the label. Keep the product in its original package to protect from moisture.

Stability and Disposal

The prepared oral solution has a limited shelf-life and typically requires refrigeration (2 C to 8 C). Do not use the medicine past the expiry date. For disposal, do not throw unused or expired Flucloxacillin into household waste or wastewater. The official instruction is to return the product to a pharmacist for safe disposal in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Флуклоксациллин found in:

A-Z Index: